The use of extracorporeal membrane oxygenation (ECMO) in patients with respiratory failure in the course of COVID-19 indicates its limited efficacy and high mortality rates. It seems that one of the conditions for the success of veno-venous ECMO (VV ECMO) in obese patients with COVID-19 is the correct qualification and rapid implementation of this method. We present two cases of obese patients with acute respiratory distress syndrome (ARDS) as a result of SARS-CoV-2 infection with the successful use of ECMO. Two 41-year-old obese patients (Case 1: BMI 31.5 kg/m 2 and Case 2: 44.5 kg/m 2 ), with pneumonia and severe respiratory failure in the course of COVID-19, underwent ECMO therapy. The Extracorporeal Life Support Organization (ELSO) guidelines were used to qualify the patients. Due to the persistence of PaO 2 /FiO 2 rate <80 for 6 h, a decision was made to implement VV ECMO. Both patients were discharged from the intensive care unit (Case 1: on day 35; Case 2: on day 22). Rapid implementation of VV ECMO in middle-aged, obese patients with ARDS in the course of COVID-19 showed a positive outcome.
【저자키워드】 COVID-19, SARS-CoV-2, Respiratory failure, ECMO, obese patients, 【초록키워드】 Efficacy, ARDS, intensive care, Pneumonia, SARS-COV-2 infection, severe respiratory failure, outcome, organization, extracorporeal membrane oxygenation, persistence, implementation, Patient, Rapid, BMI, patients, acute respiratory distress, Extracorporeal, life, syndrome, high mortality, positive, Course, condition, indicate, were used, discharged, ECMO therapy, obese patient, PaO, use of ECMO, with COVID-19, 【제목키워드】 respiratory, Extracorporeal, failure, report,